Introduction
In 2009 we identified a sizeable gap between those diagnosed with Hepatitis C (HCV) and those seen at clinic. The Northern Ireland Managed Clinical Network (MCN) has reviewed all polymerase chain reaction (PCR) positive cases with respect to referral to/attendance at clinic.
Aims/Background
To review referral to/attendance at Liver Clinic for confirmed HCV PCR positive cases.
Method
Confirmed cases between September 2009 and June 2012 were cross-referenced with the Patient Administration System to assess clinic attendance. In cases why patients were not referred, the originator of the test was contacted, for an explanation and to encourage referral to the clinic.
Results
219 cases were confirmed. 118 (53%) cases were referred before MCN intervention. After this,193 referrals were received (88%). 26 (12%) individuals were never referred. 6 persons died following referral, leaving 187 referred cases. 149(77%) individuals currently attend the liver clinic; 1 awaits appointment. 42% of referrals were from ethnic minority groups. Annual non-attendance rates dropped from 22% in 2009 to 16% in 2011. 37 patients referred did not attend clinic; 18 from ethnic minority backgrounds. 19 were from UK/Northern Ireland.
There was no significant difference between non-attendance rate amongst ethnic minority groups (22.8%) and for those with a UK/Northern Ireland origin (17.9%) (Fishers Exact Test; p= 0.46).
Conclusion
Involvement of the NI Hepatitis B&C MCN has increased rates of referral of HCV PCR positive patients for assessment. Surprisingly, ethnic background did not impact upon the rate of clinic non-attendance.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.